Data
Click on Protocol Number of interest to view study-related documentation or download data files.
(DTMC data files are under development.)
| Division | Study Number | Title Sort descending | Investigator(s) | Release Date |
|---|---|---|---|---|
| CTN | NIDA-CTN-0011 | A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities | Robert L. Hubbard, Ph.D., M.B.A. | May 18, 2007 |
| DTMC | NIDA-CSP-999 | A Multicenter Clinical Trial of Buprenorphine in Treatment of Opiate Dependence | Walter Ling, M.D., Donald R. Wesson, M.D., C. James Klett, Ph.D. | Sep 02, 2015 |
| DTMC | NIDA-CSP-1008A | A Multicenter Efficacy/Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence | Peter Bridge, M.D., Paul J. Fudala, Ph.D. | Dec 04, 2014 |
| DTMC | NIDA-CSP-1008B | A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence | Peter Bridge, M.D. | Dec 04, 2014 |
| DTMC | NIDA-CSP-1018 | A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence | Walter Ling, M.D., Paul J. Fudala, Ph.D., Paul Casadonte, M.D. | Sep 02, 2015 |
| DTMC | NIDA-CPU-0006 | A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine | Reese Jones, M.D. | May 23, 2017 |
| DTMC | NIDA-CSP-1020 | A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal | Ann Montgomery, R.N. | Dec 21, 2017 |
| CTN | NIDA-CTN-0029 | A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD | T. John Winhusen, Ph.D., Eugene Somoza, M.D. | Dec 15, 2009 |
| CTN | NIDA-CTN-0052 | A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC) | T. John Winhusen, Ph.D. | May 14, 2014 |
| CTN | NIDA-CTN-0030 | A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence | Walter Ling, M.D., Roger Weiss, M.D. | Jun 22, 2011 |